Taysha Gene TherapiesTSHA 
$2.15-1.38%24h
-1.38%24h
Global rank12788
Market cap$401.96M
Change 7d-2.71%
YTD Performance25.73%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Taysha Gene Therapies (TSHA)
As of November 2024, Taysha Gene Therapies has a market cap of $401.96M. This makes Taysha Gene Therapies the world's 12788th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Taysha Gene Therapies from 2020 to 2024
-
Value:-
Market cap history of Taysha Gene Therapies from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $292.59M | -11.58% |
| 2023 | $330.92M | -21.68% |
| 2022 | $422.53M | -80.60% |
| 2021 | $2.18B | -56.10% |
| 2020 | $4.96B | - |
TSHA Market Cap Today is $401.96M -1.38% - 2 Nov 2024
View largest stocks by market cap 
